SCHEMBL8466289

SCHEMBL8466289

C=COCC1CCCCC1CO

nearest known ligand 0.34

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.34
PABPC1 P11940 1/20 0.32
APOBEC3A P31941 1/20 0.32
APOBEC3G Q9HC16 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14554018 0.89
SCHEMBL15226772 0.89
SCHEMBL19674519 0.89
SCHEMBL15227045 0.87
SCHEMBL15227649 0.84
Vinyl Ether SCHEMBL8466299 0.80 TDP1 (0.38) TDP1PABPC1APOBEC3AAPOBEC3G
SCHEMBL19674627 0.78
Vinyl Ether SCHEMBL21647908 0.77 TDP1 (0.35) TDP1PABPC1APOBEC3AAPOBEC3G
SCHEMBL896746 0.77
SCHEMBL33527751 0.76 TSHR (0.37)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118325041-A Curable composition, method for producing cured product, and cured product thereof 株式会社ADEKA 2024-07-12 CN disclosed
US-20240210817-A1 RESIN MOLDED ARTICLE PRODUCTION METHOD AND OPTICAL COMPONENT PRODUCTION METHOD DAICEL CORPORATION (JP) 2024-06-27 US disclosed
WO-2024135086-A1 PHOTOCURABLE COMPOSITION, UNDERCOAT LAYER, LAMINATE AND DISPLAY DEVICE 株式会社ダイセル 2024-06-27 WO disclosed
CN-118185235-A Curable composition, method for producing cured product, and cured product thereof 株式会社ADEKA 2024-06-14 CN disclosed
CN-108884298-B Curable composition, method for producing cured product, and cured product thereof 株式会社ADEKA 2024-05-31 CN disclosed
CN-115279831-B Composition, cured product, and method for producing cured product 株式会社艾迪科 2024-05-31 CN disclosed
WO-2024095928-A1 EPOXY COMPOUND PRODUCT 株式会社ダイセル 2024-05-10 WO disclosed
CN-114222773-B Composition, cured product, optical filter, and method for producing cured product 株式会社艾迪科 2024-04-09 CN disclosed
WO-2024071139-A1 MULTILAYER STRUCTURE AND METHOD FOR PRODUCING SAME, AUTOMOBILE PART, AIRCRAFT PART, AND DAMPING MATERIAL FOR CARBON-FIBER-REINFORCED PLASTIC 三菱ケミカル株式会社 2024-04-04 WO disclosed
US-20240092946-A1 LIQUID, HYBRID UV/VIS RADIATION CURABLE RESIN COMPOSITIONS FOR ADDITIVE FABRICATION STRATASYS INC (US) 2024-03-21 US disclosed
EP-2995632-A1 CURABLE EPOXY RESIN COMPOSITION AND CURED PRODUCT THEREOF, DIOLEFIN COMPOUND AND PRODUCTION METHOD THEREFOR, AND PRODUCTION METHOD FOR DIEPOXY COMPOUND Daicel Corporation (JP) 2016-03-16 EP disclosed
US-20150232620-A1 CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF DAICEL CORPORATION (JP) 2015-08-20 US disclosed
EP-2907833-A1 CURABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF Daicel Corporation (JP) 2015-08-19 EP disclosed
US-8981040-B2 Cationically polymerizable resin, cationically polymerizable resin composition, and cured products thereof DAICEL CORPORATION (JP) 2015-03-17 US disclosed
US-8735462-B2 Radical-polymerizable resin, radical-polymerizable resin composition, and cured material thereof DAICEL CORPORATION (JP) 2014-05-27 US disclosed
US-20130315553-A1 APPARATUS FOR PRODUCING OPTICAL FIBER, METHOD FOR PRODUCING OPTICAL FIBER, AND OPTICAL FIBER PRODUCED BY METHOD DAICEL CORPORATION (JP) 2013-11-28 US disclosed
US-20130035465-A1 RADICAL POLYMERIZABLE RESIN, RADICAL POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF DAICEL CORPORATION (JP) 2013-02-07 US disclosed
US-20130030078-A1 RADICAL-POLYMERIZABLE RESIN, RADICAL-POLYMERIZABLE RESIN COMPOSITION, AND CURED MATERIAL THEREOF DAICEL CORPORATION (JP) 2013-01-31 US disclosed
US-20120309930-A1 CATIONICALLY POLYMERIZABLE RESIN, CATIONICALLY POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCTS THEREOF DAICEL CORPORATION (JP) 2012-12-06 US disclosed
US-5914427-A Preparation of ω-hydroxyesiers of α,β-unsaturated carboxylic acids BASF AKTIENGESELLSHAFT (DE) 1999-06-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130035465-A1 RADICAL POLYMERIZABLE RESIN, RADICAL POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCT THEREOF PTGER1, RAD51, REV1 TDP1 2508/4885PABPC1 2521/4885APOBEC3A 1916/4885
US-20120309930-A1 CATIONICALLY POLYMERIZABLE RESIN, CATIONICALLY POLYMERIZABLE RESIN COMPOSITION, AND CURED PRODUCTS THEREOF ARG1, ARGLU1, RAD51 TDP1 3103/4885PABPC1 3069/4885APOBEC3A 1679/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.